What is the recommendation of ACC/AHA Task Force Members regarding the use of Argatroban in NSTE-ACS patients?
The ACC/AHA Task Force Members recommend that Argatroban may be used in NSTE-ACS patients as part of an ischemia-guided strategy. In addition, they recommend that oral and intravenous antiplatelet agents and GP IIb/IIIa inhibitors be used in combination with Argatroban to reduce the risk of ischemic events.